Ultragenyx Pharmaceutical Inc - Company Profile
Powered by
All the data and insights you need on Ultragenyx Pharmaceutical Inc in one report.
- Save hours of research time and resources with
our up-to-date Ultragenyx Pharmaceutical Inc Strategy Report
- Understand Ultragenyx Pharmaceutical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Ultragenyx Pharmaceutical Inc (Ultragenyx) focuses on the discovery, acquisition, development and commercialization of novel products for the treatment of various rare and ultra-rare genetic diseases with unmet medical need. The company's marketed product: Dojolvi, lead product: Mepsevii, and strong patent portfolio are its major strengths, even as a history of operating losses are major causes for concern to the company. Huge competition, dependence on third party manufacturers and government regulations could affect Ultragenyx's growth prospects. However, it stands to benefit from the market potential for rare diseases, increasing healthcare expenditure in the US and regulatory approval for its products.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer